Nigeria Health Watch
Follow us:
breadcrumb banner

Lassa Fever

Categories

Blog Image 15 May

WAHO Expands Lassa Fever Coalition with new Regional Health Partners to Accelerate Vaccine Access in West Africa

By Nigeria Health Watch | May 15, 2025

Three leading West African health partners: Corona Management Systems, Nigeria Health Watch, and Bloom Public Health, have officially joined the Lassa Fever Coalition, an instrumental initiative by the West African Health Organisation (WAHO) and supported by the Coalition for Epidemic Preparedness  Innovations (CEPI), to advance the fight against the deadly haemorrhagic Lassa Fever and accelerate […]

Read More
Blog Image 7 Dec

Boosting Country Coordination and Ownership for Lassa Fever Preparedness in West Africa

By Nigeria Health Watch | December 7, 2024

Lead Writers: Ibukun Oguntola, Dr Aishat Usman, and Dr Virgil Lokossou Walking through the bustling streets of Owo, a small town in the southwestern region of Nigeria, one might encounter the vibrant energy that characterises this town. Yet, beneath this lively facade lies a significant public health challenge: Lassa fever. This persistent virus has sustained […]

Read More
Blog Image 2 Oct

Largest-ever Lassa fever study launches in-depth look at disease symptom

By Nigeria Health Watch | October 2, 2024

Scientists in Nigeria are expanding their research into the deadly Lassa fever with the launch of a pioneering study designed to get a better idea of the variation in disease symptoms and how these compare to malaria and other worrisome infections found in the region.  The new research, led by the Nigeria Centre for Disease […]

Read More
Blog Image 13 Sep

Ten Years After Ebola: Learnings for Lassa Fever, “Lassa-X” and Pandemic Preparedness

By Nigeria Health Watch | September 13, 2024

Oluomachukwu Omeje (Lead Writer) In global health, past epidemics are important learning experiences that shape our responses to future health emergencies. The 2014 Ebola epidemic in West Africa serves as a stark reminder of the vulnerabilities and strengths of public health systems. As the world continues to face emerging and re-emerging infectious diseases, the lessons […]

Read More
Blog Image 4 Apr

Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

By Nigeria Health Watch | April 4, 2024

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI’s single dose Lassa fever vaccine candidate Key takeaways • Participants in Nigeria have been vaccinated with a Lassa fever vaccine candidate in the first Phase 2 clinical trial of any Lassa vaccine.• Lassa fever is a deadly hemorrhagic fever common to West Africa. […]

Read More